These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 15881695

  • 1. Glycopeptide and oxacillin activity against Staphylococcus aureus isolates at a tertiary care center in Lebanon.
    Kanj SS, Ghaleb PA, Araj GF.
    J Med Liban; 2004; 52(1):8-12. PubMed ID: 15881695
    [Abstract] [Full Text] [Related]

  • 2. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D, Toshkova K, Gavrilova V.
    Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
    Bernard L, Vaudaux P, Rohner P, Huggler E, Armanet M, Pittet D, Lew DP, Schrenzel J.
    J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063
    [Abstract] [Full Text] [Related]

  • 4. [Multi-center evaluation to discriminate between the strains of methicillin-resistant Staphylococcus aureus (MRSA) and those susceptible (MSSA) by Showa oxacillin and methicillin disk susceptibility tests].
    Takahashi A, Yamane N, Igari J, Oguri T, Toyoshima S, Moriyasu I, Takemori K, Tosaka M, Minamide W.
    Rinsho Byori; 1994 Sep; 42(9):953-60. PubMed ID: 7967120
    [Abstract] [Full Text] [Related]

  • 5. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G, White R, Friedrich L.
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [Abstract] [Full Text] [Related]

  • 6. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL, Cheron M, Benabid D, Leneveu M, Boisivon A, Association of Hospital Bacteriologists, Virologists and Hygiene Professionals.
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [Abstract] [Full Text] [Related]

  • 7. [Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
    Voss A, Machka K, Lenz W, Milatovic D.
    Dtsch Med Wochenschr; 1992 Dec 11; 117(50):1907-12. PubMed ID: 1459021
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug 11; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 9. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C, Denis O, Struelens MJ.
    Clin Microbiol Infect; 2005 Mar 11; 11(3):214-20. PubMed ID: 15715719
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
    Hussain FM, Boyle-Vavra S, Shete PB, Daum RS.
    J Infect Dis; 2002 Sep 01; 186(5):661-7. PubMed ID: 12195353
    [Abstract] [Full Text] [Related]

  • 11. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A, Schubert S.
    Int J Antimicrob Agents; 2010 Sep 01; 36(3):216-21. PubMed ID: 20630710
    [Abstract] [Full Text] [Related]

  • 12. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    Alós JI, García-Cañas A, García-Hierro P, Rodríguez-Salvanés F.
    J Antimicrob Chemother; 2008 Oct 01; 62(4):773-5. PubMed ID: 18552338
    [Abstract] [Full Text] [Related]

  • 13. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M, Ermertcan S, Taşli H, Kurutepe S.
    Mikrobiyol Bul; 2007 Oct 01; 41(4):511-6. PubMed ID: 18173069
    [Abstract] [Full Text] [Related]

  • 14. [Performance of different methods of oxacillin resistance detection in atypic strains of Staphylococcus aureus].
    Hamdad F, Donda F, Laurans G, Canarelli B, Rousseau F, Biendo M, Thomas D, Eb F.
    Pathol Biol (Paris); 2006 Oct 01; 54(8-9):447-52. PubMed ID: 17030459
    [Abstract] [Full Text] [Related]

  • 15. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK, Wennersten C, Venkataraman L, Eliopoulos GM, Moellering RC, Karchmer AW.
    Clin Infect Dis; 2009 Oct 15; 49(8):1169-74. PubMed ID: 19769538
    [Abstract] [Full Text] [Related]

  • 16. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb 15; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 17. [Multi-center evaluation of Showa ceftizoxime disk susceptibility test to discriminate between the strains of methicillin-resistant Staphylococcus aureus (MRSA) and those susceptible (MSSA)].
    Moriyasu I, Igari J, Yamane N, Oguri T, Takahashi A, Tosaka M, Takemori K, Toyoshima S, Minamide W.
    Rinsho Byori; 1994 Mar 15; 42(3):271-7. PubMed ID: 8152163
    [Abstract] [Full Text] [Related]

  • 18. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
    Hawser SP, Bouchillon SK, Hoban DJ, Dowzicky M, Babinchak T.
    Int J Antimicrob Agents; 2011 Mar 15; 37(3):219-24. PubMed ID: 21239146
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
    Samra Z, Ofer O, Shmuely H.
    Isr Med Assoc J; 2005 Mar 15; 7(3):148-50. PubMed ID: 15792257
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides.
    Anwar MS, Bokhari SR.
    J Coll Physicians Surg Pak; 2003 Jan 15; 13(1):33-6. PubMed ID: 12685973
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.